The North America Oral Anti-Diabetic Drug Market size is expected to grow from USD 17.92 billion in 2023 to USD 22.54 billion by 2028, at a CAGR of 4.70%.
The Latin America Oral Anti-Diabetic Drug Market size is expected to grow from USD 3.14 billion in 2023 to USD 3.73 billion by 2028, at a CAGR of 3.50%.